Dr. Ashvin Baru , MD
Internal Medicine - Nephrology โข Austin, TX
321 W Ben White Blvd Ste 205
Austin, TX 787047087
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Ashvin Baru is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on March 31, 2011; this date does not establish years in practice.
-
Published CMS data list 1,378 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99233 โ Subsequent hospital care with moderate levelof medical decision making: 271 service units.
- 99232 โ Subsequent hospital care with moderate levelof medical decision making: 251 service units.
- 90960 โ Dialysis services, 4 or more physician visits per month (20 years or older): 248 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 13 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,622 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Farxiga (Dapagliflozin Propanediol) โ 131 prescription fills, including refills.
- Losartan Potassium โ 111 prescription fills, including refills.
- Nifedipine Er (Nifedipine) โ 90 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 45 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Nephrology in Austin, TX (2024, 33 clinicians with data). Median for this group: 988. Middle half: 786 to 1,271.
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: 1,229. Middle half: 627 to 2,176.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,644 in 2020 to 1,378 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
321 W Ben White Blvd Ste 205
Austin, TX 787047087
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Austin Kidney Associates Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2011
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
363 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $207,728 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $158,051 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
3,316 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$580,198 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $441.25 across 13 records.
By nature of payment
- Food and Beverage: $441.25 across 13 records.
Reporting-company totals (3 largest of 9)
- Calliditas Therapeutics US Inc.: $181.58 across 3 records.
- Novartis Pharmaceuticals Corporation: $80.51 across 3 records.
- Veloxis Pharmaceuticals, Inc.: $34.24 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
15 years (graduated 2011)
CMS Doctors and Clinicians data list 2011 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2011
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Baru has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Baru as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Austin and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Nephrology in Austin, TX (2024, 33 clinicians with data). Median for this group: 988. Middle half: 786 to 1,271.
Close to the middle for clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: 1,229. Middle half: 627 to 2,176.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Nephrology in Austin, TX (2024, 33 clinicians with data). Median for this group: $142,051. Middle half: $98,960 to $162,230.
A higher Medicare-allowed amount than 70% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: $146,330. Middle half: $81,178 to $228,491.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine - Nephrology in Austin, TX (2024, 33 clinicians with data). Median for this group: $108,099. Middle half: $76,945 to $124,901.
A higher Medicare payment amount than 70% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 900 clinicians with data). Median for this group: $112,021. Middle half: $63,642 to $175,741.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Internal Medicine - Nephrology in Austin, TX (2024, 34 clinicians with data). Median for this group: 988. Middle half: 666 to 1,231.
More Part D prescriptions than 70% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 890 clinicians with data). Median for this group: 976. Middle half: 396 to 1,679.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine - Nephrology in Austin, TX (2024, 34 clinicians with data). Median for this group: $174,464. Middle half: $48,045 to $225,043.
A higher Part D drug cost than 85% of clinicians listed under Internal Medicine - Nephrology in Texas (2024, 890 clinicians with data). Median for this group: $157,200. Middle half: $45,012 to $339,428.
45 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Austin, TX (1,161 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Austin
33.3% of these 45 clinicians have the CMS telehealth indicator.
75.6% of these 45 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 48% from 2,644 in 2020 to 1,378 in 2024.
- 2020: 2,644
- 2021: 1,958
- 2022: 1,811
- 2023: 1,242
- 2024: 1,378
-
Medicare-allowed amount
Medicare-allowed amount decreased 45% from $374,684 in 2020 to $207,728 in 2024.
- 2020: $374,684
- 2021: $323,065
- 2022: $298,219
- 2023: $223,540
- 2024: $207,728
-
Paid by Medicare
Paid by Medicare decreased 46% from $291,371 in 2020 to $158,051 in 2024.
- 2020: $291,371
- 2021: $251,485
- 2022: $232,568
- 2023: $172,790
- 2024: $158,051
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 63% from 994 in 2020 to 1,622 in 2024.
- 2020: 994
- 2021: 1,034
- 2022: 1,180
- 2023: 1,328
- 2024: 1,622
-
30-day fills
30-day fills increased 61% from 2,062 in 2020 to 3,316 in 2024.
- 2020: 2,062
- 2021: 2,151
- 2022: 2,652
- 2023: 2,890
- 2024: 3,316
-
Part D drug cost
Part D drug cost increased 490% from $98,267 in 2020 to $580,198 in 2024.
- 2020: $98,267
- 2021: $159,996
- 2022: $223,208
- 2023: $358,791
- 2024: $580,198
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $131.66 in 2021 to $441.25 in 2025.
- 2021: $131.66
- 2022: $43.78
- 2023: $72.48
- 2024: $303.57
- 2025: $441.25
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 13 records totaling $441.25.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $124.72 |
| Veloxis Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ENVARSUS | General | $34.24 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
JYNARQUE | General | $32.53 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $31.08 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $30.70 |
| AKEBIA THERAPEUTICS INC |
Food and Beverage
In-kind items and services
|
Vafseo | General | $30.00 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ULTOMIRIS | General | $26.94 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $26.52 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $26.16 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Vanrafia | General | $22.91 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
NUCALA | General | $20.80 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $19.47 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $15.18 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
271 | 103 | $185.00 | $113.30 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
251 | 108 | $130.00 | $75.00 |
|
90960
Dialysis services, 4 or more physician visits per month (20 years or older)
|
248 | 40 | $1800.00 | $332.12 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
155 | 111 | $18.00 | $15.73 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
117 | 78 | $190.00 | $93.78 |
|
90961
Dialysis services, 2-3 physician visits per month (20 years or older)
|
74 | 31 | $1200.00 | $277.17 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
62 | 58 | $355.00 | $165.57 |
|
90966
Home dialysis services per month (20 years or older)
|
51 | 14 | $1800.00 | $281.88 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
39 | 36 | $250.00 | $121.72 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
37 | 32 | $130.00 | $84.45 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
33 | 21 | $255.00 | $112.40 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
25 | 25 | $301.80 | $162.98 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
15 | 15 | $200.00 | $107.66 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Farxiga | Dapagliflozin Propanediol | 131 | 7,380 | $133,879.79 | 30 |
| Losartan Potassium | Losartan Potassium | 111 | 8,960 | $1,032.36 | 35 |
| Nifedipine Er | Nifedipine | 90 | 5,875 | $2,030.27 | 32 |
| Furosemide | Furosemide | 89 | 6,682 | $711.92 | 39 |
| Sevelamer Carbonate | Sevelamer Carbonate | 77 | 4,557 | $21,805.34 | 28 |
| Amlodipine Besylate | Amlodipine Besylate | 76 | 5,363 | $550.93 | 26 |
| Carvedilol | Carvedilol | 75 | 4,665 | $494.34 | 25 |
| Valsartan | Valsartan | 58 | 3,060 | $2,055.05 | 17 |
| Doxazosin Mesylate | Doxazosin Mesylate | 56 | 4,320 | $857.61 | 19 |
| Mounjaro | Tirzepatide | 51 | 1,430 | $51,046.82 | โ |
| Metoprolol Succinate | Metoprolol Succinate | 49 | 2,683 | $624.28 | โ |
| Veltassa | Patiromer Calcium Sorbitex | 48 | 1,920 | $54,304.83 | 15 |
| Ozempic | Semaglutide | 46 | 1,600 | $41,675.18 | 12 |
| Tamsulosin Hcl | Tamsulosin Hcl | 40 | 2,640 | $603.48 | 12 |
| Jardiance | Empagliflozin | 40 | 1,950 | $39,607.68 | 11 |
| Gabapentin | Gabapentin | 39 | 2,010 | $290.66 | 14 |
| Calcium Acetate | Calcium Acetate | 35 | 2,000 | $4,265.28 | 16 |
| Trulicity | Dulaglutide | 35 | 1,092 | $37,965.30 | โ |
| Calcitriol | Calcitriol | 33 | 2,655 | $621.04 | 11 |
| Atorvastatin Calcium | Atorvastatin Calcium | 27 | 1,950 | $83.71 | โ |
| Lisinopril | Lisinopril | 25 | 1,950 | $115.04 | 11 |
| Allopurinol | Allopurinol | 24 | 2,160 | $201.60 | โ |
| Potassium Chloride | Potassium Chloride | 22 | 900 | $167.12 | โ |
| Spironolactone | Spironolactone | 22 | 1,880 | $201.86 | โ |
| Velphoro | Sucroferric Oxyhydroxide | 22 | 804 | $112,199.10 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-07-21NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20160629002327
TX
0042455750
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Austin Kidney Associates Pa
408 W 45th St, Austin, TX 787513014
Phone: 5124515800
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Clinical Nurse Specialist - Adult Health
Clinical Nurse Specialist
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Clinical Nurse Specialist - Adult Health
Nurse Practitioner - Family
Family Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 321 W BEN WHITE BLVD STE 205, AUSTIN, TX 787047087 (Tel: 1232015005)
NPI status registered as active in NPPES database
Registered at 408 W 45TH ST, AUSTIN, TX 787513014 (Tel: 5124515800)
Registered at 408 W 45TH ST, AUSTIN, TX 787513014 (Tel: 5124515800)
Recorded as ASHVIN BARU, M.D.
Internal Medicine (license number reported to NPPES: TX Q7838)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Austin
- David Vadala
- Dr. Michelle Lubetzky, MD
- Dr. Cristian Cipleu, MD
- Dr. Vincent Tjia, MD
- Dr. Mark Rosen, MD
- Dr. Peter Miller, MD
Mailing Address
408 W 45th St
Austin, TX 787513014
Phone: 5124515800